BINDER

Gordon Binder & Weiss Vision Institute in San Diego Launches Innovative New Website

A top vision care practice in San Diego, California is opening its virtual doors to the worldwide web with new, cutting-edge technology. The Gordon Binder & Weiss Vision Institute is using internet video and other advanced tools on a new website designed to educate visitors as to how they can...

Nephrologists Indicate High Interest in AMAG Pharmaceuticals' Newly Approved Feraheme According to Latest BioTrends Report

...rior authorizations" and "adequate reimbursement". In the phosphate binder market, Genzyme's sevelamer compounds are being used to treat almost half o... the need for new ESA and IV iron therapies. Particularly in the phosphate binder market, there are a number of important product attributes where current pr...

Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe

...ciences Limited, a wholly-owned subsidiary of CTI, based in London, UK. About Pixantrone Pixantrone (BBR 2778) is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review

...lure, myocardial infarction, cyanosis, pericardial effusion, and tachycardia. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award

...ompound provides an osteoconductive, biologic scaffold onto which new bone can form during the window of healing. The Mg gives the cement a powerful binder quality that theoretically allows it to resist tensile forces at time zero, thereby potentially limiting graft-tunnel motion. Several in vivo animal a...

Pixantrone Now Available in Europe on a Named-Patient Basis

... can be found at http://www.celltherapeutics.com/pixantrone_europe About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group

... await the approval of AMAG's Feraheme and familiarity with the product is on the rise. Product shifts have also been the theme in the phosphate binder market where use of Genzyme's Renvela continues to take hold primarily at the expense of Genzyme's Renagel, although the move away from calcium-based ...

Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone

...g the review process to begin before the complete dossier has been submitted. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Researchers clone key sperm-binding proteins

...al Molecular Human Reproduction , the researchers have become the first to clone, produce and purify a protein important for sperm maturation, termed binder of Sperm (BSP), which may have implications for both fertility treatments and new methods of male contraception. "We have previously isolated and c...

Ranbaxy Secures Final FDA Approval for Quinapril Hydrochloride + Hydrochlorothiazide Tablets

... (609) 720-5615 Edwige Buteau RF binder Partners Inc. (212) 994-7517 Caroline Dickson RF binder Partners Inc. (212) 994-7560 ...

BINDER in Medical Technology

Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th

...9. Pixantrone is also now available in Europe on a named-patient basis. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Pixantrone in Combination with Chemotherapy Regimens Produces Overall Response Rates of 58-74% with Complete Remission Rates of 37-57% in Relapsed/Refractory Aggressive or Indolent NHL

...Hancock, M.D., Professor of Medical Oncology, Weston Park Hospital, Shefield. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment

... Pixantrone is also now available in Europe on a named patient basis. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting

.... Food and Drug Administration ("FDA") during the fourth quarter of 2009. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium

... Authors: Carol Allen DaVita Inc., Selma, CA -- Title: binder Consumption as a Function of Time: A Linear Model for Lowering Elevated Phosphorus Levels by Improving binder Timing Authors: Mark A. Livingston DaVita Inc., Warren, ...

Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma

..., differentiating it from anthracycline chemotherapy agents, was discovered by our scientists in Bresso, Italy. Pixantrone is a novel DNA major groove binder that contains an aza- anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents. Anthracyclines have been shown t...

Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone

..., differentiating it from anthracycline chemotherapy agents, was discovered by our scientists in Bresso, Italy. Pixantrone is a novel DNA major groove binder that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents. Anthracyclines have been shown to...

Pixantrone Increases Progression-Free Survival by 81% Compared to Standard Chemotherapeutic Agents in Phase III Relapsed Aggressive non-Hodgkin's Lymphoma Trial

..., differentiating it from anthracycline chemotherapy agents, was discovered by our scientists in Bresso, Italy. Pixantrone is a novel DNA major groove binder that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents. Anthracyclines have been shown to...

Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission

..., differentiating it from anthracycline chemotherapy agents, was discovered by our scientists in Bresso, Italy. Pixantrone is a novel DNA major groove binder that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents. Anthracyclines have been shown to...

Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint

..., differentiating it from anthracycline chemotherapy agents, was discovered by our scientists in Bresso, Italy. Pixantrone is a novel DNA major groove binder that contains an aza-anthracenedione molecular structure, differentiating it from anthracycline chemotherapy agents. Anthracyclines have been shown to...

BINDER in Medical Products

Abdominal Binder w/Velcro

Description: Abdominal Binder w / Velcro...
Company:AART, Inc.

Universal Binder - 2-Panel

Description: CDIs 2-Panel Abdominal Binders are designed with a foam backing which provides comfort, support and compression without slippage....
Company:Contemporary Design Inc.

Universal Binder

Description: CDIs Abdominal Binders are designed with a non-pitching, body contouring, non-rolling elastic band that provides both support and compression. Available in 9, 12 and 15 widths with waist ranges from 24 to 62....
Company:Contemporary Design Inc.

Male Compression Vest Binder

Description: Male Compression Vest Binder...
Company:Contemporary Design Inc.

2518 ELASTIC ABDOMINAL BINDER

Description: This lightweight, full length 10" elastic binder has a variety of applications. Its most common use is as an abdominal binder for post-surgical dressings. It is effective in supporting abdominal contents when there has been a loss of muscle tone. It can also be used as a rib belt to prevent pain...
Company:Truform-OTC

Universal Torso Shoulder Immobilizer

Description:... Universal Torso Shoulder Immobilizer A chest binder with shoulder strap. 3/8" foam with contact closure. Humerus strap extends to attach posteriorly. Movable wrist cuff. Plastic stay. 1 " web shoulder s...
Company:AliMed, Inc.

Abdominal Compression for Men and Women

Features:... Elastic and Velcro© combine for optimal abdominal compression Flexible side stays prevent the Ab binder from rolling Recommended for upper and lower abdominal support and compression May be worn with body garments for additional compression ...
Company:Rainey Compressions Essentials

Male Abdominal Supporter

Features:... Most popular male garment Athletic supporter keeps binder in place Hook and eye side closure Can be ordered with suspenders ...
Company:Morris Designs Inc.

More>>

BINDER in Medical Dictionary

Paints

...wide. ... Welcome to ICI Paints . Select your region to find local product and service information. ... Artists paints are a simple compound of binder and pigment. ... Oil paints most commonly use poppy oil, linseed oil or safflower oil as a binder. ... Manufactures decorative paints , automot...

BINDER in Biological News

Coating copies microscopic biological surfaces

...ical surface structures. "Only a small fraction of mutations in evolutionary processes are successful," says Akhlesh Lakhtakia, the Charles Godfrey binder (Endowed) Professor of Engineering Science and Mechanics. "But, evolution has gone on for at least a billion years. A huge range of biological surface...

Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2008

...artment of Energy's Global Nuclear Energy Partnership. Program Manager Jeff binder of the Nuclear Science and Technology Division said conventional reprocessi...tinides (uranium, neptunium and plutonium) and are a proliferation concern. binder said the ORNL technique, called modified direct denitration, converts a ura...

BINDER in Biological Technology

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... product entered new countries, and continued to grow in countries entered in the last two years. In the US, FOSRENOL's average share of the phosphate binder market in Q2 2009 declined to 7.8% (2008: 8.2%) due to a 3% decrease in prescriptions. However, US product sales grew 15% as price increases offset th...

Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients

... earlier studies, suggest that Zerenex is an effective, tolerated phosphate binder that will potentially make a significant clinical addition to treating the ...es that there is significant market potential for the drug in the phosphate binder space." Mr. Bentsur continued, "We're excited to have two late stage clinic...

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

...9. Pixantrone is also now available in Europe on a named patient basis. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

Low Occurrence of Severe Cardiac Side Effects Despite Extensive Prior Doxorubicin Treatment Reported in Pixantrone Pivotal Trial

... Pixantrone is also now available in Europe on a named-patient basis. About Pixantrone Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines a...

ChartTrends(R): Bone and Mineral Metabolism in Dialysis Reveals Latest Trends in the Treatment of Calcium, Phosphorus and PTH

... treatment of hyperphosphatemia, patients tend to be initiated on phosphate binder monotherapy when phosphorus reaches 5.7 mg/dL. Phosphorus levels are signi...ary to what Nephrologists perceive based on self-reported data, combination binder therapy is prescribed infrequently. Genzyme's sevelamer is the market shar...

Shire begins the year with a strong performance

...d as the product entered new countries, and continued to grow in countries entered in the last two years. FOSRENOL's average share of the US phosphate binder market decreased to 7.8% (2008: 8.2%) and despite a 2% decrease in prescriptions product sales increased, primarily due to price increases. Dur...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ar to December 31, 2008 were up 38% to $85.9 million compared to 2007 (2007: $62.1 million). FOSRENOL's average prescription share of the US phosphate binder retail market decreased to 8.1% for the year to December 31, 2008 (2007: 8.6%). Product sales increased despite the decrease in prescriptions due to p...

BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism

.... Many potential new products are also on the horizon in the phosphate binder market, albeit longer term. New products will likely be welcome additions a...f their patients are not well-controlled on currently available binders. A binder that could be given with less frequency (as opposed to every meal) would li...

EcoSphere(R) Biolatex(TM) Secures Funding from Granholm and Invest Michigan!

...ing process next year. "One of the reasons for our success is the fact that our new biolatex replaces a large percentage of petroleum-based binder in the paper coating process," states Richard Shatkosky, President of EcoSynthetix. "With the wildly fluctuating price of petroleum products...

European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTrends Report

...alcium based phosphate binders are the most frequently prescribed binders in both dialysis and CKD, however, there is a high prevalence of combination binder therapy typically involving a calcium based agent combined with Genzyme's Renagel. Future share projections appear to favor Shire's Fosrenol which co...

BINDER in Biological Products

Hybridization chamber with forced convection BFD 53 from BINDER

Description: BFD Series Hybridization chambers with forced convection Temperature range 5 C / 9 F above ambient up to 99.9 C / 212 F Patented APT.line preheating chamber assuring temperature accuracy and reproducible results DS controller Timer 0 to 24 h Digital temperature setting with an accuracy of a t...
Company:BINDER

BINDER in Biological Definition

Chromatography

...hemical reactions and for the qualitative analysis of reaction products. TLC plates are made by mixing the adsorbent with a small amount of inert binder like calcium sulfate (gypsum) and water, spreading the a thick slurry on the carrier, drying the plate, and activation of the adsorbent by heating i...